title: Burn injury impairs second-set rejection and CTL reactivity in mice primed by cultured keratinocyte allografts.
abstract: Cultured keratinocyte (CK) allografts have limited antigenicity and have been used as a skin replacement in patients with massive thermal injury. Recent data indicate that CK grafts are more immunogenic than previously believed and could compromise wound healing in the immunocompetent host. The purpose of this study was to determine if the immunosuppression of burn injury might affect the alloantigen response and minimize sensitization to CK allografts. CBA mice received a 0%, 20%, or 40% burn that was partially excised three days later and grafted with a full-thickness (FT) skin allograft, CK allograft, or CK autograft. Two weeks postburn, mice received FT tail skin allografts, which were observed for rejection. We observed that FT and CK allografts primed the unburned host with equal efficacy. However, burn injury selectively minimized priming by CK allografts, resulting in delayed rejection of second-set allografts. With evidence that burn injury inhibits host sensitization to CK allografts, we then examined the effect of burn size on CTL alloreactivity. Additional CBA mice underwent burn injury, excision, and grafting as described above. Host splenocytes were harvested two weeks later and tested on radiolabeled targets for allospecific cytotoxicity. CTLs from unburned mice primed with FT allografts demonstrated the greatest CTL lysis, followed next by CTLs from unburned mice covered with CK allografts. Burn injury inhibited CTL activity as a function of wound size. Activity of CTLs from burned mice primed with CK allografts improved after in vitro allostimulation but remained below that of CTLs from unburned, unprimed mice. We conclude that burn injury selectively inhibits the allospecific response to CK allografts. The decreased immunogenicity of CK allografts, when used for burn wound coverage, may improve the long-term survival of allogeneic keratinocytes, enhancing their potential as a biologic skin replacement.
authors.affiliation: Department of Surgery, School of Medicine, University of North Carolina, Chapel Hill 27599-7210, USA.
authors.forename: C S
authors.initials: CS
authors.lastname: Hultman
authors.forename: B A
authors.initials: BA
authors.lastname: Cairns
authors.forename: S
authors.initials: S
authors.lastname: deSerres
authors.forename: J A
authors.initials: JA
authors.lastname: Frelinger
authors.forename: A A
authors.initials: AA
authors.lastname: Meyer
mesh_terms: D000818:Animals; D002056:Burns / Q000276:immunology*; D003602:Cytotoxicity, Immunologic; D006084:Graft Rejection; D007156:Immunologic Memory; D007165:Immunosuppression Therapy; D015603:Keratinocytes / Q000276:immunology*; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D016038:Skin Transplantation / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology*; D013997:Time Factors